Health
Synthetic Mini-Antibody Identified to Combat COVID-19 – SciTechDaily
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to…
SARS-CoV-2’s ability to infect cells relies on interactions between the viral spike protein (magenta) and the protein ACE2 (blue), which is present on the surface of human cells. These interactions can be disrupted by sybodies (black) — synthetic mini-antibodies similar to those produced by camels and llamas. Credit: Rayne Zaayman-Gallant/EMBL
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus…
-
General23 hours agoTrump’s tariffs: a bad idea executed badly
-
Business4 hours agoSoaring one day, plunging the next. Why is the ASX 200 on a rollercoaster?
-
Business10 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Noosa News6 hours agoBrisbane man Benjamin Holt speaks out about teen who allegedly organised Airbnb party that led to his house being trashed